4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

C41H58N2O4 — CID 123677083

IUPAC4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESC=CC1CCC2(NC(=O)CN3CCOCC3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12
InChIInChI=1S/C41H58N2O4/c1-7-27-14-19-41(42-34(44)26-43-22-24-47-25-23-43)21-20-39(5)31(35(27)41)12-13-33-38(4)17-15-30(28-8-10-29(11-9-28)36(45)46)37(2,3)32(38)16-18-40(33,39)6/h7-11,15,27,31-33,35H,1,12-14,16-26H2,2-6H3,(H,42,44)(H,45,46)
InChIKeyPKYSTVVXBAILKL-UHFFFAOYSA-N
MW642.93 g/mol
LogP7.85
Rot. Bonds6

About 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid

4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (PubChem CID 123677083) has the molecular formula C41H58N2O4 and a molecular weight of 642.93 g/mol. Its IUPAC name is 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.

Molecular Properties

Compound Name4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
PubChem CID123677083
Molecular FormulaC41H58N2O4
Molecular Weight642.93 g/mol
Exact Mass642.44
IUPAC Name4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid
SMILESC=CC1CCC2(NC(=O)CN3CCOCC3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12
InChIInChI=1S/C41H58N2O4/c1-7-27-14-19-41(42-34(44)26-43-22-24-47-25-23-43)21-20-39(5)31(35(27)41)12-13-33-38(4)17-15-30(28-8-10-29(11-9-28)36(45)46)37(2,3)32(38)16-18-40(33,39)6/h7-11,15,27,31-33,35H,1,12-14,16-26H2,2-6H3,(H,42,44)(H,45,46)
InChIKeyPKYSTVVXBAILKL-UHFFFAOYSA-N
XLogP7.85
TPSA78.87 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds6
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500642.93
LogP ≤ 57.85
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The IUPAC name of 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (CID 123677083) is 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.
What is the SMILES notation for 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The canonical SMILES for 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is C=CC1CCC2(NC(=O)CN3CCOCC3)CCC3(C)C(CCC4C5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)C5CCC43C)C12.
What is the InChIKey of 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
The InChIKey is PKYSTVVXBAILKL-UHFFFAOYSA-N. The full InChI is InChI=1S/C41H58N2O4/c1-7-27-14-19-41(42-34(44)26-43-22-24-47-25-23-43)21-20-39(5)31(35(27)41)12-13-33-38(4)17-15-30(28-8-10-29(11-9-28)36(45)46)37(2,3)32(38)16-18-40(33,39)6/h7-11,15,27,31-33,35H,1,12-14,16-26H2,2-6H3,(H,42,44)(H,45,46).
What are the key properties of 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid?
4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid has a molecular weight of 642.93 g/mol, XLogP of 7.85, 6 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[1-ethenyl-5a,5b,8,8,11a-pentamethyl-3a-[(2-morpholin-4-ylacetyl)amino]-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid is sourced from PubChem (CID 123677083), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).